approved EB-2 (NIW)

Senior Development Scientist

Medicinal Chemistry · Bangladesh · 2022-04-19

Processing Time
69 days
Decision Date
2022-04-19
Location
Massachusetts
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue analyzing synthetic routes to isolate, synthesize, design, and ensure the safety of novel drug molecules. This work is part of innovative drug discovery projects aimed at treating cancer, heart disease, and infectious diseases to improve global and U.S. healthcare outcomes.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses cancer and heart disease, which are leading causes of death in the U.S. and globally.

2 Well-positioned to Advance the Endeavor Met

The petitioner has a record of 22 publications, 181 citations, and has received funding from the NIH.

3 Waiver Benefit Met

The petitioner's expertise in drug safety and synthesis provides a significant benefit to U.S. healthcare that outweighs the need for a labor certification.

Why This Petition Was Approved

The case was approved based on the petitioner's 22 peer-reviewed journal articles (6 first-authored) and 181 citations. Evidence included funding from the National Institutes of Health (NIH) and detailed documentation of four key projects demonstrating her expertise in drug discovery.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Grants
Original Contributions
Government Alignment

Similar Cases

Postdoctoral Researcher

Pharmaceuticals · Vietnam

WeGreened EB-2 (NIW) approved
278 days 2025-01-11
The petitioner proposes to identify and analyze novel bioactive compounds isolated from natural sources with distinct chemical diversity. This work aims to accelerate the development of new pharmaceuticals for chronic diseases that currently lack adequate treatments, such as diabetes, cardiovascular disease, and osteoporosis.

Scientist

Pharmaceuticals · India

WeGreened EB-2 (NIW) approved
Wisconsin 94 days 2025-01-29
The petitioner proposes to investigate the design, synthesis, optimization, and characterization of small molecule compounds. This work focuses on developing therapeutic agents to address drug-resistant infections and improve medication safety and efficacy.

Chemist

Pharmaceuticals · China

WeGreened EB-2 (NIW) rfe approved
Pennsylvania 364 days 2025-11-26
The petitioner proposes to develop practical and efficient synthetic routes to produce active pharmaceutical ingredients (APIs) for drugs currently in clinical trials. This work focuses on improving scalable production methods to reduce costs and shorten development timelines for new therapies targeting cancer and neurodegenerative disorders.

Research Assistant

Pharmaceuticals · China

WeGreened EB-2 (NIW) approved
California 426 days 2025-01-08
The petitioner proposes to continue research in pharmaceutical chemistry with a focus on drug discovery optimization and the development of advanced computational techniques. This work involves identifying new therapeutics for human diseases and creating computational methods that offer significant advantages over conventional drug discovery approaches. The intended impact is to reduce the economic and social costs of disease while improving global public health.

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2022-04-19.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 69 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist